Fintel on MSN9h
TD Cowen Upgrades Sana Biotechnology (SANA)
Fintel reports that on January 8, 2025, TD Cowen upgraded their outlook for Sana Biotechnology (NasdaqGS:SANA) from Hold to ...
McCormick upgraded to Buy at TD Cowen on well-positioned portfolio
As previously reported, TD Cowen upgraded McCormick (MKC) to Buy from Hold with a price target of $90, up from $86. The firm views McCormick’s ...
TD Cowen upgrades Cardinal Health (CAH) to a Buy
Cardinal Health (CAH – Research Report) received a Buy rating and a $144.00 price target from TD Cowen analyst Charles Rhyee today. The ...
Fintel on MSN21h
TD Cowen Initiates Coverage of Centessa Pharmaceuticals plc - Depositary Receipt () (CNTA) with Buy Recommendation
Fintel reports that on January 7, 2025, TD Cowen initiated coverage of Centessa Pharmaceuticals plc - Depositary Receipt () ...
Consumer staples facing a tougher 2025 on MAHA initiatives, pivot to tech - analyst
“Two-thousand-twenty-four was a tough year for staples stocks, and 2025 is shaping up to be even tougher,” says TD Cowen ...
Healthcare Dive7h
Health insurers will step off the roller coaster in 2025
After a turbulent year, things should calm for payers with the advent of a business-friendly Trump administration — though challenges will persist. Here are experts’ biggest predictions for 2025.